Xarelto's generic name is rivaroxaban [1].
What is rivaroxaban used for?
Rivaroxaban is an anticoagulant, commonly known as a blood thinner [1]. It is prescribed to prevent and treat blood clots in various conditions, including deep vein thrombosis (DVT) and pulmonary embolism (PE) [2]. It is also used to reduce the risk of stroke in patients with non-valvular atrial fibrillation [2]. Additionally, rivaroxaban is used after certain surgeries, such as hip or knee replacement, to prevent blood clots [2].
How does rivaroxaban work?
Rivaroxaban is a direct factor Xa inhibitor [3]. Factor Xa is a crucial enzyme in the blood clotting cascade. By inhibiting factor Xa, rivaroxaban effectively reduces the formation of thrombin, which is essential for clot development [3]. This mechanism helps to prevent the formation of dangerous blood clots.
When does Xarelto (rivaroxaban) patent expire?
Information regarding the specific patent expiry dates for Xarelto (rivaroxaban) can be found on DrugPatentWatch.com [4]. Patent and exclusivity statuses can be complex and may involve multiple patents covering different aspects of the drug, including formulation and method of use [4].
Are there generic versions of rivaroxaban available?
As of recent information, generic versions of rivaroxaban have become available [5]. The introduction of generics typically follows patent expiry and regulatory approval processes.
What are the alternatives to rivaroxaban?
Other anticoagulants are available as alternatives to rivaroxaban. These include warfarin (a vitamin K antagonist), and other direct oral anticoagulants (DOACs) such as apixaban, dabigatran, and edoxaban [2]. The choice of anticoagulant depends on individual patient factors, including medical history, other medications, and physician recommendation [2].
What are the risks associated with rivaroxaban?
The primary risk associated with rivaroxaban, like other anticoagulants, is bleeding [1]. This can range from minor bruising or nosebleeds to severe, life-threatening hemorrhages [1]. Other potential side effects may include dizziness, fatigue, and gastrointestinal upset [1]. Patients taking rivaroxaban should be closely monitored by their healthcare provider [1].
Sources:
[1] https://www.mayoclinic.org/drugs-supplements/rivaroxaban-oral-route/proper-use/drg-20068423
[2] https://www.nhs.uk/medicines/rivaroxaban/
[3] https://www.ema.europa.eu/en/medicines/human/EPAR/xarelto
[4] https://www.drugpatentwatch.com/
[5] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/rivaroxaban-and-and-potential-new-drug-shortages